News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rumor Mill: Is Volcano Corporation Ripe For A Buyout?



11/14/2013 8:44:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Diagnostics and stents maker Volcano (NSDQ:VOLC) may be primed for acquisition, with a raft of analysts' groups debating only the timing of a buy. Volcano's stents and stent placement and evaluation technologies could draw buyers from some of medtech's biggest players, such as Medtronic (NYSE:MDT) and Abbott (NYSE:ABT), according to market reports. Engaged Capital, which owns a significant stake in the company, recommended patience, saying the company may garner a higher price if it waits to sell.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES